nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Isoprenaline—MAPK1—multiple sclerosis	0.00859	0.24	CrCbGaD
Labetalol—Quinapril—SLC15A2—multiple sclerosis	0.00842	0.236	CrCbGaD
Labetalol—Benazepril—SLC15A2—multiple sclerosis	0.00733	0.205	CrCbGaD
Labetalol—CYP2D6—Fingolimod—multiple sclerosis	0.00724	0.804	CbGbCtD
Labetalol—Mirabegron—BCHE—multiple sclerosis	0.00582	0.163	CrCbGaD
Labetalol—Mirabegron—ALB—multiple sclerosis	0.00239	0.0669	CrCbGaD
Labetalol—CYP2D6—Dexamethasone—multiple sclerosis	0.00177	0.196	CbGbCtD
Labetalol—Syncope—Prednisolone—multiple sclerosis	0.00149	0.00171	CcSEcCtD
Labetalol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00149	0.0017	CcSEcCtD
Labetalol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00148	0.00169	CcSEcCtD
Labetalol—Somnolence—Mitoxantrone—multiple sclerosis	0.00147	0.00169	CcSEcCtD
Labetalol—Loss of consciousness—Prednisolone—multiple sclerosis	0.00146	0.00168	CcSEcCtD
Labetalol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00146	0.00167	CcSEcCtD
Labetalol—Hypertension—Prednisolone—multiple sclerosis	0.00144	0.00165	CcSEcCtD
Labetalol—Fatigue—Mitoxantrone—multiple sclerosis	0.00143	0.00164	CcSEcCtD
Labetalol—Fenoprofen—ALB—multiple sclerosis	0.00143	0.04	CrCbGaD
Labetalol—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00142	0.00163	CcSEcCtD
Labetalol—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00142	0.00162	CcSEcCtD
Labetalol—Constipation—Mitoxantrone—multiple sclerosis	0.00142	0.00162	CcSEcCtD
Labetalol—Pain—Mitoxantrone—multiple sclerosis	0.00142	0.00162	CcSEcCtD
Labetalol—Bradycardia—Prednisone—multiple sclerosis	0.00142	0.00162	CcSEcCtD
Labetalol—Alopecia—Betamethasone—multiple sclerosis	0.00141	0.00162	CcSEcCtD
Labetalol—Alopecia—Dexamethasone—multiple sclerosis	0.00141	0.00162	CcSEcCtD
Labetalol—Diarrhoea—Azathioprine—multiple sclerosis	0.0014	0.00161	CcSEcCtD
Labetalol—Discomfort—Prednisolone—multiple sclerosis	0.0014	0.0016	CcSEcCtD
Labetalol—Angioedema—Triamcinolone—multiple sclerosis	0.0014	0.0016	CcSEcCtD
Labetalol—Angioedema—Methylprednisolone—multiple sclerosis	0.0014	0.0016	CcSEcCtD
Labetalol—Erythema—Dexamethasone—multiple sclerosis	0.00139	0.00159	CcSEcCtD
Labetalol—Erythema—Betamethasone—multiple sclerosis	0.00139	0.00159	CcSEcCtD
Labetalol—Hallucination—Prednisone—multiple sclerosis	0.00138	0.00158	CcSEcCtD
Labetalol—Malaise—Triamcinolone—multiple sclerosis	0.00138	0.00158	CcSEcCtD
Labetalol—Malaise—Methylprednisolone—multiple sclerosis	0.00138	0.00158	CcSEcCtD
Labetalol—Vertigo—Triamcinolone—multiple sclerosis	0.00138	0.00158	CcSEcCtD
Labetalol—Syncope—Triamcinolone—multiple sclerosis	0.00137	0.00157	CcSEcCtD
Labetalol—Vertigo—Methylprednisolone—multiple sclerosis	0.00137	0.00157	CcSEcCtD
Labetalol—Syncope—Methylprednisolone—multiple sclerosis	0.00137	0.00157	CcSEcCtD
Labetalol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00137	0.00156	CcSEcCtD
Labetalol—Oedema—Prednisolone—multiple sclerosis	0.00136	0.00156	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00136	0.00156	CcSEcCtD
Labetalol—Dysuria—Methotrexate—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Labetalol—Dizziness—Azathioprine—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Labetalol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Labetalol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00135	0.00154	CcSEcCtD
Labetalol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00134	0.00154	CcSEcCtD
Labetalol—Shock—Prednisolone—multiple sclerosis	0.00134	0.00153	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00134	0.00153	CcSEcCtD
Labetalol—Hypertension—Triamcinolone—multiple sclerosis	0.00132	0.00151	CcSEcCtD
Labetalol—Hypertension—Methylprednisolone—multiple sclerosis	0.00132	0.00151	CcSEcCtD
Labetalol—Urticaria—Mitoxantrone—multiple sclerosis	0.00132	0.00151	CcSEcCtD
Labetalol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00131	0.00151	CcSEcCtD
Labetalol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00131	0.0015	CcSEcCtD
Labetalol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00131	0.0015	CcSEcCtD
Labetalol—Vomiting—Azathioprine—multiple sclerosis	0.0013	0.00149	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Rash—Azathioprine—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Dermatitis—Azathioprine—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Depression—Methotrexate—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Flushing—Prednisone—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Discomfort—Triamcinolone—multiple sclerosis	0.00129	0.00148	CcSEcCtD
Labetalol—Discomfort—Methylprednisolone—multiple sclerosis	0.00129	0.00147	CcSEcCtD
Labetalol—Headache—Azathioprine—multiple sclerosis	0.00128	0.00147	CcSEcCtD
Labetalol—Angioedema—Betamethasone—multiple sclerosis	0.00127	0.00145	CcSEcCtD
Labetalol—Angioedema—Dexamethasone—multiple sclerosis	0.00127	0.00145	CcSEcCtD
Labetalol—Confusional state—Methylprednisolone—multiple sclerosis	0.00126	0.00144	CcSEcCtD
Labetalol—Malaise—Dexamethasone—multiple sclerosis	0.00125	0.00144	CcSEcCtD
Labetalol—Malaise—Betamethasone—multiple sclerosis	0.00125	0.00144	CcSEcCtD
Labetalol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Oedema—Triamcinolone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Vertigo—Dexamethasone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Vertigo—Betamethasone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Syncope—Dexamethasone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Syncope—Betamethasone—multiple sclerosis	0.00125	0.00143	CcSEcCtD
Labetalol—Sweating—Methotrexate—multiple sclerosis	0.00124	0.00142	CcSEcCtD
Labetalol—Shock—Triamcinolone—multiple sclerosis	0.00123	0.00141	CcSEcCtD
Labetalol—Alopecia—Prednisone—multiple sclerosis	0.00123	0.00141	CcSEcCtD
Labetalol—Shock—Methylprednisolone—multiple sclerosis	0.00123	0.00141	CcSEcCtD
Labetalol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Paraesthesia—Prednisolone—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Mental disorder—Prednisone—multiple sclerosis	0.00122	0.0014	CcSEcCtD
Labetalol—Nausea—Azathioprine—multiple sclerosis	0.00122	0.00139	CcSEcCtD
Labetalol—Erythema—Prednisone—multiple sclerosis	0.00121	0.00139	CcSEcCtD
Labetalol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00121	0.00138	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—multiple sclerosis	0.00121	0.00138	CcSEcCtD
Labetalol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00121	0.00138	CcSEcCtD
Labetalol—Hypertension—Betamethasone—multiple sclerosis	0.0012	0.00137	CcSEcCtD
Labetalol—Hypertension—Dexamethasone—multiple sclerosis	0.0012	0.00137	CcSEcCtD
Labetalol—Asthenia—Mitoxantrone—multiple sclerosis	0.00119	0.00136	CcSEcCtD
Labetalol—Discomfort—Betamethasone—multiple sclerosis	0.00117	0.00134	CcSEcCtD
Labetalol—Discomfort—Dexamethasone—multiple sclerosis	0.00117	0.00134	CcSEcCtD
Labetalol—Hypotension—Methylprednisolone—multiple sclerosis	0.00117	0.00134	CcSEcCtD
Labetalol—Pain—Prednisolone—multiple sclerosis	0.00116	0.00133	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—multiple sclerosis	0.00116	0.00133	CcSEcCtD
Labetalol—Vision blurred—Prednisone—multiple sclerosis	0.00114	0.00131	CcSEcCtD
Labetalol—Oedema—Dexamethasone—multiple sclerosis	0.00113	0.0013	CcSEcCtD
Labetalol—Oedema—Betamethasone—multiple sclerosis	0.00113	0.0013	CcSEcCtD
Labetalol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00113	0.0013	CcSEcCtD
Labetalol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00113	0.0013	CcSEcCtD
Labetalol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00113	0.0013	CcSEcCtD
Labetalol—Ill-defined disorder—Prednisone—multiple sclerosis	0.00112	0.00129	CcSEcCtD
Labetalol—Paraesthesia—Triamcinolone—multiple sclerosis	0.00112	0.00129	CcSEcCtD
Labetalol—Feeling abnormal—Prednisolone—multiple sclerosis	0.00112	0.00128	CcSEcCtD
Labetalol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00112	0.00128	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—multiple sclerosis	0.00112	0.00128	CcSEcCtD
Labetalol—Shock—Dexamethasone—multiple sclerosis	0.00112	0.00128	CcSEcCtD
Labetalol—Shock—Betamethasone—multiple sclerosis	0.00112	0.00128	CcSEcCtD
Labetalol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00111	0.00128	CcSEcCtD
Labetalol—Angioedema—Prednisone—multiple sclerosis	0.00111	0.00127	CcSEcCtD
Labetalol—Dyspepsia—Triamcinolone—multiple sclerosis	0.0011	0.00126	CcSEcCtD
Labetalol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.0011	0.00126	CcSEcCtD
Labetalol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.0011	0.00126	CcSEcCtD
Labetalol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.0011	0.00126	CcSEcCtD
Labetalol—Malaise—Prednisone—multiple sclerosis	0.00109	0.00125	CcSEcCtD
Labetalol—Vertigo—Prednisone—multiple sclerosis	0.00109	0.00125	CcSEcCtD
Labetalol—Syncope—Prednisone—multiple sclerosis	0.00109	0.00124	CcSEcCtD
Labetalol—Urticaria—Prednisolone—multiple sclerosis	0.00108	0.00124	CcSEcCtD
Labetalol—Fatigue—Triamcinolone—multiple sclerosis	0.00108	0.00123	CcSEcCtD
Labetalol—Fatigue—Methylprednisolone—multiple sclerosis	0.00108	0.00123	CcSEcCtD
Labetalol—Pain—Triamcinolone—multiple sclerosis	0.00107	0.00122	CcSEcCtD
Labetalol—Loss of consciousness—Prednisone—multiple sclerosis	0.00106	0.00122	CcSEcCtD
Labetalol—Hypotension—Betamethasone—multiple sclerosis	0.00106	0.00121	CcSEcCtD
Labetalol—Hypotension—Dexamethasone—multiple sclerosis	0.00106	0.00121	CcSEcCtD
Labetalol—Vomiting—Mitoxantrone—multiple sclerosis	0.00105	0.00121	CcSEcCtD
Labetalol—Hypertension—Prednisone—multiple sclerosis	0.00105	0.0012	CcSEcCtD
Labetalol—Rash—Mitoxantrone—multiple sclerosis	0.00104	0.0012	CcSEcCtD
Labetalol—Dermatitis—Mitoxantrone—multiple sclerosis	0.00104	0.0012	CcSEcCtD
Labetalol—Headache—Mitoxantrone—multiple sclerosis	0.00104	0.00119	CcSEcCtD
Labetalol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00103	0.00118	CcSEcCtD
Labetalol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00103	0.00118	CcSEcCtD
Labetalol—Alopecia—Methotrexate—multiple sclerosis	0.00103	0.00118	CcSEcCtD
Labetalol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00102	0.00117	CcSEcCtD
Labetalol—Paraesthesia—Dexamethasone—multiple sclerosis	0.00102	0.00117	CcSEcCtD
Labetalol—Paraesthesia—Betamethasone—multiple sclerosis	0.00102	0.00117	CcSEcCtD
Labetalol—Discomfort—Prednisone—multiple sclerosis	0.00102	0.00117	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—multiple sclerosis	0.00102	0.00117	CcSEcCtD
Labetalol—Erythema—Methotrexate—multiple sclerosis	0.00101	0.00116	CcSEcCtD
Labetalol—Hypersensitivity—Prednisolone—multiple sclerosis	0.001	0.00115	CcSEcCtD
Labetalol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000999	0.00114	CcSEcCtD
Labetalol—Dyspepsia—Betamethasone—multiple sclerosis	0.000999	0.00114	CcSEcCtD
Labetalol—Urticaria—Triamcinolone—multiple sclerosis	0.000993	0.00114	CcSEcCtD
Labetalol—Urticaria—Methylprednisolone—multiple sclerosis	0.000991	0.00113	CcSEcCtD
Labetalol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000988	0.00113	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000988	0.00113	CcSEcCtD
Labetalol—Oedema—Prednisone—multiple sclerosis	0.000988	0.00113	CcSEcCtD
Labetalol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000986	0.00113	CcSEcCtD
Labetalol—Nausea—Mitoxantrone—multiple sclerosis	0.000984	0.00113	CcSEcCtD
Labetalol—Fatigue—Dexamethasone—multiple sclerosis	0.000978	0.00112	CcSEcCtD
Labetalol—Fatigue—Betamethasone—multiple sclerosis	0.000978	0.00112	CcSEcCtD
Labetalol—Shock—Prednisone—multiple sclerosis	0.000972	0.00111	CcSEcCtD
Labetalol—Pain—Betamethasone—multiple sclerosis	0.00097	0.00111	CcSEcCtD
Labetalol—Pain—Dexamethasone—multiple sclerosis	0.00097	0.00111	CcSEcCtD
Labetalol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000955	0.00109	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—multiple sclerosis	0.000953	0.00109	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000939	0.00108	CcSEcCtD
Labetalol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000935	0.00107	CcSEcCtD
Labetalol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000935	0.00107	CcSEcCtD
Labetalol—Flurbiprofen—ALB—multiple sclerosis	0.000932	0.0261	CrCbGaD
Labetalol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000928	0.00106	CcSEcCtD
Labetalol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000928	0.00106	CcSEcCtD
Labetalol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000921	0.00105	CcSEcCtD
Labetalol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000919	0.00105	CcSEcCtD
Labetalol—Malaise—Methotrexate—multiple sclerosis	0.000912	0.00104	CcSEcCtD
Labetalol—Vertigo—Methotrexate—multiple sclerosis	0.000909	0.00104	CcSEcCtD
Labetalol—Urticaria—Dexamethasone—multiple sclerosis	0.000901	0.00103	CcSEcCtD
Labetalol—Urticaria—Betamethasone—multiple sclerosis	0.000901	0.00103	CcSEcCtD
Labetalol—Dizziness—Prednisolone—multiple sclerosis	0.000899	0.00103	CcSEcCtD
Labetalol—Asthenia—Triamcinolone—multiple sclerosis	0.000897	0.00103	CcSEcCtD
Labetalol—Body temperature increased—Betamethasone—multiple sclerosis	0.000897	0.00103	CcSEcCtD
Labetalol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000897	0.00103	CcSEcCtD
Labetalol—Abdominal pain—Betamethasone—multiple sclerosis	0.000897	0.00103	CcSEcCtD
Labetalol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000897	0.00103	CcSEcCtD
Labetalol—Asthenia—Methylprednisolone—multiple sclerosis	0.000895	0.00103	CcSEcCtD
Labetalol—Paraesthesia—Prednisone—multiple sclerosis	0.000887	0.00102	CcSEcCtD
Labetalol—Pruritus—Triamcinolone—multiple sclerosis	0.000885	0.00101	CcSEcCtD
Labetalol—Pruritus—Methylprednisolone—multiple sclerosis	0.000883	0.00101	CcSEcCtD
Labetalol—Dyspepsia—Prednisone—multiple sclerosis	0.00087	0.000996	CcSEcCtD
Labetalol—Rash—Prednisolone—multiple sclerosis	0.000857	0.000982	CcSEcCtD
Labetalol—Dermatitis—Prednisolone—multiple sclerosis	0.000856	0.000981	CcSEcCtD
Labetalol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000853	0.000978	CcSEcCtD
Labetalol—Fatigue—Prednisone—multiple sclerosis	0.000852	0.000975	CcSEcCtD
Labetalol—Headache—Prednisolone—multiple sclerosis	0.000852	0.000975	CcSEcCtD
Labetalol—Discomfort—Methotrexate—multiple sclerosis	0.000851	0.000975	CcSEcCtD
Labetalol—Constipation—Prednisone—multiple sclerosis	0.000845	0.000968	CcSEcCtD
Labetalol—Ketoprofen—ALB—multiple sclerosis	0.000843	0.0236	CrCbGaD
Labetalol—Confusional state—Methotrexate—multiple sclerosis	0.000832	0.000953	CcSEcCtD
Labetalol—Dizziness—Triamcinolone—multiple sclerosis	0.000827	0.000947	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000826	0.000946	CcSEcCtD
Labetalol—Dizziness—Methylprednisolone—multiple sclerosis	0.000825	0.000945	CcSEcCtD
Labetalol—Feeling abnormal—Prednisone—multiple sclerosis	0.000814	0.000932	CcSEcCtD
Labetalol—Asthenia—Dexamethasone—multiple sclerosis	0.000814	0.000932	CcSEcCtD
Labetalol—Asthenia—Betamethasone—multiple sclerosis	0.000814	0.000932	CcSEcCtD
Labetalol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000808	0.000925	CcSEcCtD
Labetalol—Nausea—Prednisolone—multiple sclerosis	0.000808	0.000925	CcSEcCtD
Labetalol—Pruritus—Betamethasone—multiple sclerosis	0.000803	0.000919	CcSEcCtD
Labetalol—Pruritus—Dexamethasone—multiple sclerosis	0.000803	0.000919	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000798	0.000914	CcSEcCtD
Labetalol—Vomiting—Triamcinolone—multiple sclerosis	0.000795	0.00091	CcSEcCtD
Labetalol—Vomiting—Methylprednisolone—multiple sclerosis	0.000793	0.000908	CcSEcCtD
Labetalol—Rash—Triamcinolone—multiple sclerosis	0.000788	0.000903	CcSEcCtD
Labetalol—Dermatitis—Triamcinolone—multiple sclerosis	0.000788	0.000902	CcSEcCtD
Labetalol—Rash—Methylprednisolone—multiple sclerosis	0.000787	0.000901	CcSEcCtD
Labetalol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000786	0.0009	CcSEcCtD
Labetalol—Urticaria—Prednisone—multiple sclerosis	0.000785	0.000899	CcSEcCtD
Labetalol—Headache—Triamcinolone—multiple sclerosis	0.000783	0.000897	CcSEcCtD
Labetalol—Headache—Methylprednisolone—multiple sclerosis	0.000781	0.000895	CcSEcCtD
Labetalol—Abdominal pain—Prednisone—multiple sclerosis	0.000781	0.000894	CcSEcCtD
Labetalol—Body temperature increased—Prednisone—multiple sclerosis	0.000781	0.000894	CcSEcCtD
Labetalol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000776	0.000889	CcSEcCtD
Labetalol—Diarrhoea—Betamethasone—multiple sclerosis	0.000776	0.000889	CcSEcCtD
Labetalol—Hypotension—Methotrexate—multiple sclerosis	0.000771	0.000884	CcSEcCtD
Labetalol—Dizziness—Dexamethasone—multiple sclerosis	0.00075	0.000859	CcSEcCtD
Labetalol—Dizziness—Betamethasone—multiple sclerosis	0.00075	0.000859	CcSEcCtD
Labetalol—Nausea—Triamcinolone—multiple sclerosis	0.000743	0.000851	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—multiple sclerosis	0.000741	0.000849	CcSEcCtD
Labetalol—Nausea—Methylprednisolone—multiple sclerosis	0.000741	0.000849	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—multiple sclerosis	0.000736	0.000843	CcSEcCtD
Labetalol—Somnolence—Methotrexate—multiple sclerosis	0.000734	0.000841	CcSEcCtD
Labetalol—Hypersensitivity—Prednisone—multiple sclerosis	0.000728	0.000834	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—multiple sclerosis	0.000727	0.000832	CcSEcCtD
Labetalol—Vomiting—Dexamethasone—multiple sclerosis	0.000721	0.000826	CcSEcCtD
Labetalol—Vomiting—Betamethasone—multiple sclerosis	0.000721	0.000826	CcSEcCtD
Labetalol—Rash—Betamethasone—multiple sclerosis	0.000715	0.000819	CcSEcCtD
Labetalol—Rash—Dexamethasone—multiple sclerosis	0.000715	0.000819	CcSEcCtD
Labetalol—Dermatitis—Dexamethasone—multiple sclerosis	0.000715	0.000818	CcSEcCtD
Labetalol—Dermatitis—Betamethasone—multiple sclerosis	0.000715	0.000818	CcSEcCtD
Labetalol—Fatigue—Methotrexate—multiple sclerosis	0.000712	0.000815	CcSEcCtD
Labetalol—Headache—Betamethasone—multiple sclerosis	0.000711	0.000814	CcSEcCtD
Labetalol—Headache—Dexamethasone—multiple sclerosis	0.000711	0.000814	CcSEcCtD
Labetalol—Asthenia—Prednisone—multiple sclerosis	0.000709	0.000812	CcSEcCtD
Labetalol—Pain—Methotrexate—multiple sclerosis	0.000706	0.000809	CcSEcCtD
Labetalol—Pruritus—Prednisone—multiple sclerosis	0.000699	0.000801	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—multiple sclerosis	0.00068	0.000779	CcSEcCtD
Labetalol—Diarrhoea—Prednisone—multiple sclerosis	0.000676	0.000774	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000675	0.000773	CcSEcCtD
Labetalol—Nausea—Betamethasone—multiple sclerosis	0.000674	0.000772	CcSEcCtD
Labetalol—Nausea—Dexamethasone—multiple sclerosis	0.000674	0.000772	CcSEcCtD
Labetalol—Urticaria—Methotrexate—multiple sclerosis	0.000656	0.000751	CcSEcCtD
Labetalol—Dizziness—Prednisone—multiple sclerosis	0.000653	0.000748	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—multiple sclerosis	0.000653	0.000748	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—multiple sclerosis	0.000653	0.000748	CcSEcCtD
Labetalol—Vomiting—Prednisone—multiple sclerosis	0.000628	0.000719	CcSEcCtD
Labetalol—Rash—Prednisone—multiple sclerosis	0.000623	0.000713	CcSEcCtD
Labetalol—Dermatitis—Prednisone—multiple sclerosis	0.000622	0.000713	CcSEcCtD
Labetalol—Headache—Prednisone—multiple sclerosis	0.000619	0.000709	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000608	0.000697	CcSEcCtD
Labetalol—Asthenia—Methotrexate—multiple sclerosis	0.000592	0.000678	CcSEcCtD
Labetalol—Nausea—Prednisone—multiple sclerosis	0.000587	0.000672	CcSEcCtD
Labetalol—Pruritus—Methotrexate—multiple sclerosis	0.000584	0.000669	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—multiple sclerosis	0.000565	0.000647	CcSEcCtD
Labetalol—Dizziness—Methotrexate—multiple sclerosis	0.000546	0.000625	CcSEcCtD
Labetalol—Vomiting—Methotrexate—multiple sclerosis	0.000525	0.000601	CcSEcCtD
Labetalol—Rash—Methotrexate—multiple sclerosis	0.000521	0.000596	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—multiple sclerosis	0.00052	0.000596	CcSEcCtD
Labetalol—Headache—Methotrexate—multiple sclerosis	0.000517	0.000592	CcSEcCtD
Labetalol—Nausea—Methotrexate—multiple sclerosis	0.00049	0.000562	CcSEcCtD
Labetalol—ADRB3—Signaling by GPCR—CCR1—multiple sclerosis	0.000285	0.00347	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL13—multiple sclerosis	0.000285	0.00347	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000281	0.00342	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000279	0.0034	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000273	0.00333	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TAGAP—multiple sclerosis	0.000262	0.00319	CbGpPWpGaD
Labetalol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000258	0.00315	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000258	0.00314	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CCL5—multiple sclerosis	0.000256	0.00312	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000253	0.00308	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000252	0.00307	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000248	0.00301	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000237	0.00289	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	0.000235	0.00286	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000232	0.00283	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000232	0.00282	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CCR5—multiple sclerosis	0.000231	0.00281	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	0.00023	0.0028	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00023	0.0028	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—S1PR1—multiple sclerosis	0.000229	0.00278	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000227	0.00276	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000226	0.00276	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000225	0.00274	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GPC5—multiple sclerosis	0.000222	0.00271	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000221	0.0027	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000219	0.00266	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000216	0.00262	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000215	0.00262	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000214	0.0026	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	0.000213	0.00259	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00021	0.00256	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00021	0.00256	CbGpPWpGaD
Labetalol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000209	0.00255	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000208	0.00253	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	0.000208	0.00253	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000206	0.0025	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000204	0.00248	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL3—multiple sclerosis	0.000203	0.00248	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000203	0.00247	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0002	0.00243	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	0.0002	0.00243	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	0.000196	0.00239	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000196	0.00238	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000195	0.00238	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	0.000195	0.00238	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RGS1—multiple sclerosis	0.000194	0.00237	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	0.000192	0.00234	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	0.000191	0.00233	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000189	0.0023	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000187	0.00228	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000187	0.00227	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000187	0.00227	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	0.000185	0.00226	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GPR65—multiple sclerosis	0.000184	0.00224	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCR2—multiple sclerosis	0.000184	0.00224	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000182	0.00222	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000182	0.00222	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	0.000181	0.00221	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—POMC—multiple sclerosis	0.00018	0.0022	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00018	0.00219	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	0.000179	0.00218	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000177	0.00215	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CCL2—multiple sclerosis	0.000177	0.00215	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000176	0.00214	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	0.000175	0.00213	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000173	0.00211	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CNR1—multiple sclerosis	0.00017	0.00207	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000169	0.00206	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	0.000169	0.00206	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL13—multiple sclerosis	0.000169	0.00205	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR1—multiple sclerosis	0.000169	0.00205	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000168	0.00205	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000166	0.00202	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	0.000166	0.00202	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	0.000155	0.00189	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000153	0.00186	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	0.000152	0.00185	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	0.000152	0.00185	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	0.000149	0.00181	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000145	0.00176	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000141	0.00171	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000138	0.00168	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000138	0.00168	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	0.000137	0.00167	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	0.000136	0.00165	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000135	0.00164	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	0.000134	0.00163	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	0.000133	0.00162	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	0.000132	0.00161	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL5—multiple sclerosis	0.000132	0.0016	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000131	0.00159	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	0.000129	0.00157	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000129	0.00157	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000128	0.00156	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000125	0.00152	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000124	0.0015	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000121	0.00147	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	0.000121	0.00147	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00012	0.00146	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL3—multiple sclerosis	0.00012	0.00146	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SRM—multiple sclerosis	0.00012	0.00146	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCR5—multiple sclerosis	0.000119	0.00144	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	0.000118	0.00144	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000118	0.00143	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000117	0.00142	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000116	0.00141	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTGER4—multiple sclerosis	0.000116	0.00141	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	0.000115	0.00141	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PGR—multiple sclerosis	0.000114	0.00139	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000114	0.00138	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	0.000113	0.00137	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000112	0.00137	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCR3—multiple sclerosis	0.000112	0.00136	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000111	0.00135	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000111	0.00135	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CD28—multiple sclerosis	0.000111	0.00135	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00011	0.00134	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	0.000109	0.00133	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	0.000109	0.00133	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR2—multiple sclerosis	0.000109	0.00132	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000109	0.00132	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	0.000107	0.0013	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	0.000107	0.0013	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	0.000107	0.0013	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	0.000105	0.00128	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	0.000105	0.00128	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	0.000103	0.00125	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—POMC—multiple sclerosis	0.000102	0.00124	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	0.000101	0.00123	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CNR1—multiple sclerosis	0.0001	0.00122	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	0.0001	0.00122	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	0.0001	0.00122	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	9.99e-05	0.00122	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	9.85e-05	0.0012	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	9.79e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	9.79e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	9.77e-05	0.00119	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—POMC—multiple sclerosis	9.26e-05	0.00113	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	9.07e-05	0.0011	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL2—multiple sclerosis	9.06e-05	0.0011	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL10—multiple sclerosis	9.03e-05	0.0011	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	8.87e-05	0.00108	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	8.6e-05	0.00105	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	8.46e-05	0.00103	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	8.46e-05	0.00103	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	8.41e-05	0.00102	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—TYK2—multiple sclerosis	8.23e-05	0.001	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CD86—multiple sclerosis	7.89e-05	0.000961	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	7.81e-05	0.000951	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL5—multiple sclerosis	7.77e-05	0.000946	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	7.75e-05	0.000943	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPC5—multiple sclerosis	7.74e-05	0.000942	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	7.64e-05	0.00093	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.63e-05	0.000929	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	7.58e-05	0.000923	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	7.54e-05	0.000918	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.47e-05	0.000909	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	7.2e-05	0.000876	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	7.13e-05	0.000868	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	7.03e-05	0.000856	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	7e-05	0.000852	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	6.98e-05	0.000849	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	6.93e-05	0.000844	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	6.9e-05	0.00084	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	6.88e-05	0.000838	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	6.86e-05	0.000836	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	6.85e-05	0.000834	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	6.78e-05	0.000826	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	6.76e-05	0.000823	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	6.71e-05	0.000817	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	6.63e-05	0.000807	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	6.61e-05	0.000805	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	6.57e-05	0.0008	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	6.48e-05	0.000789	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	6.45e-05	0.000785	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	6.42e-05	0.000782	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—RRM1—multiple sclerosis	6.41e-05	0.00078	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—multiple sclerosis	6.37e-05	0.000775	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	6.31e-05	0.000768	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	6.05e-05	0.000737	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	5.95e-05	0.000725	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	5.92e-05	0.000721	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	5.82e-05	0.000709	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CD80—multiple sclerosis	5.76e-05	0.000701	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	5.5e-05	0.000669	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—POMC—multiple sclerosis	5.47e-05	0.000666	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	5.38e-05	0.000655	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	5.38e-05	0.000655	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	5.36e-05	0.000652	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	5.35e-05	0.000652	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	5.26e-05	0.000641	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	5.24e-05	0.000638	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	5.24e-05	0.000638	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	4.88e-05	0.000595	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	4.86e-05	0.000592	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	4.78e-05	0.000582	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	4.69e-05	0.00057	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	4.61e-05	0.000562	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	4.58e-05	0.000558	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	4.51e-05	0.000549	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	4.48e-05	0.000545	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	4.38e-05	0.000533	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	4.27e-05	0.00052	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	4.18e-05	0.000509	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	4.16e-05	0.000506	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	4.1e-05	0.000499	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	4.06e-05	0.000495	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	4.06e-05	0.000495	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL2—multiple sclerosis	4.05e-05	0.000492	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	4.02e-05	0.00049	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	4.01e-05	0.000488	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	3.98e-05	0.000484	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	3.83e-05	0.000466	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	3.78e-05	0.00046	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	3.7e-05	0.00045	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.68e-05	0.000448	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	3.42e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	3.4e-05	0.000414	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	3.34e-05	0.000407	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	3.25e-05	0.000395	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	3.18e-05	0.000387	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	3.18e-05	0.000387	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MYC—multiple sclerosis	3.16e-05	0.000385	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	3.16e-05	0.000384	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	3.11e-05	0.000379	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	3.11e-05	0.000378	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	3.09e-05	0.000377	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	3.04e-05	0.00037	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	2.89e-05	0.000351	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	2.82e-05	0.000344	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	2.4e-05	0.000292	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	2.39e-05	0.000291	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—multiple sclerosis	2.38e-05	0.000289	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	2.35e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	2.34e-05	0.000285	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	2.27e-05	0.000277	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	2.22e-05	0.000271	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—multiple sclerosis	2.21e-05	0.00027	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	2.02e-05	0.000246	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	1.98e-05	0.000241	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—POMC—multiple sclerosis	1.9e-05	0.000232	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	1.88e-05	0.000229	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	1.87e-05	0.000228	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	1.84e-05	0.000224	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	1.84e-05	0.000224	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	1.83e-05	0.000223	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	1.8e-05	0.000219	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—multiple sclerosis	1.73e-05	0.000211	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	1.41e-05	0.000172	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	1.38e-05	0.000168	CbGpPWpGaD
